These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17874856)

  • 1. [In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
    Quindós G; Carrillo-Muñoz AJ; Eraso E; Cantón E; Pemán J
    Rev Iberoam Micol; 2007 Sep; 24(3):198-208. PubMed ID: 17874856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro susceptibility of fungal and yeast clinical isolates to itraconazole and voriconazole].
    Morera-López Y; Torres-Rodríguez JM; Jiménez-Cabello T
    Rev Iberoam Micol; 2005 Jun; 22(2):105-9. PubMed ID: 16107169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
    Guinea J; Peláez T; Recio S; Torres-Narbona M; Bouza E
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1396-400. PubMed ID: 18212101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole: therapeutic review of a new azole antifungal.
    Herbrecht R
    Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
    Miyazaki M; Horii T; Hata K; Watanabe NA; Nakamoto K; Tanaka K; Shirotori S; Murai N; Inoue S; Matsukura M; Abe S; Yoshimatsu K; Asada M
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4652-8. PubMed ID: 21825291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the safety and efficacy of voriconazole.
    Hoffman HL; Rathbun RC
    Expert Opin Investig Drugs; 2002 Mar; 11(3):409-29. PubMed ID: 11866669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Voriconazole-medicalneeds, evidence, potential for the future].
    Shirasawa H; Nagino K
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):223-8. PubMed ID: 16282963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
    Cecil JA; Wenzel RP
    Expert Rev Hematol; 2009 Jun; 2(3):237-54. PubMed ID: 21082966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K; Tredup A; Salvenmoser S; Müller FM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole for serious fungal infections.
    Gothard P; Rogers TR
    Int J Clin Pract; 2004 Jan; 58(1):74-80. PubMed ID: 14994974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole -- better chances for patients with invasive mycoses.
    Ghannoum MA; Kuhn DM
    Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole: a new triazole antifungal agent.
    Johnson LB; Kauffman CA
    Clin Infect Dis; 2003 Mar; 36(5):630-7. PubMed ID: 12594645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole : a review of its use in the management of invasive fungal infections.
    Scott LJ; Simpson D
    Drugs; 2007; 67(2):269-98. PubMed ID: 17284090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voriconazole: a new triazole antifungal.
    Sabo JA; Abdel-Rahman SM
    Ann Pharmacother; 2000 Sep; 34(9):1032-43. PubMed ID: 10981251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of voriconazole in the treatment of emerging mycoses].
    Pastor FJ; Guarro J
    Rev Iberoam Micol; 2007 Sep; 24(3):228-32. PubMed ID: 17874861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.